|
2024
|
Invention
|
Il-8 inhibitors for use in the treatment and/or prevention of bacterial secondary infections.
Th... |
|
|
Invention
|
C5ar inhibitors for use in the treatment of chemotherapy-induced iatrogenic pain.
The present in... |
|
|
Invention
|
Ngf isoform for use in the treatment of ocular pathologies.
The present invention relates to the... |
|
|
G/S
|
Pharmaceuticals; analgesic products; Antipyretic preparations; Anti-inflammatory preparations. |
|
|
G/S
|
Pharmaceuticals, namely analgesic products, Antipyretic preparations, Anti-inflammatory preparati... |
|
|
Invention
|
Composition based on plant extracts useful for the treatment of dyslipidaemias. The present inven... |
|
|
Invention
|
Auris formulations for treating otic diseases and conditions.
Disclosed herein are compositions ... |
|
|
Invention
|
Method of obtaining recombinant human brain-derived neurotrophic factor. The present invention re... |
|
|
Invention
|
Stable monohydrate of df2755a and process for its preparation. The present invention relates to a... |
|
|
Invention
|
Method for predicting cocrystal formation and control unit configured therefore. A method of pred... |
|
|
Invention
|
C5ar1 inhibitors for use in the treatment of ocular mucous membrane pemphigoid and/or oral mucous... |
|
|
Invention
|
Cxcl8 inhibitors for use in the treatment of ocular mucous membrane pemphigoid and/or oral mucous... |
|
2023
|
G/S
|
Ophthalmic preparations |
|
|
Invention
|
Ngf for the treatment of spasticity. The present invention relates to nerve growth factor (NGF) o... |
|
|
Invention
|
Intranasal administration of bdnf for the treatment of sensorineural hearing loss. The present in... |
|
|
Invention
|
Intranasal administration of ngf for the treatment of sensorineural hearing loss. The present inv... |
|
|
Invention
|
Combination for use in ophthalmology. The present invention relates to a combination of nerve gro... |
|
|
Invention
|
Reparixin liquid suspensions. The present invention relates to stable, ready-to-use liquid suspen... |
|
|
Invention
|
Powder mixture comprising reparixin. The present invention relates to a powder mixture of reparix... |
|
|
Invention
|
Il-8 inhibitors for use in the treatment of some sarcomas.
The present invention relates to IL-8... |
|
|
Invention
|
Gpr120 agonists for the treatment of inflammatory bowel disease. The present invention relates to... |
|
2022
|
Invention
|
Isocyclosporin a for topical treatment of ocular diseases. The present invention relates to isocy... |
|
|
Invention
|
Method for preparing a salt of isocyclosporin a. The present invention belongs to the technical f... |
|
|
G/S
|
Downloadable computer software for use in identifying new drugs, namely, software that is able to... |
|
|
G/S
|
Computer software relating to the medical field; computer
software for use in medical decision s... |
|
|
G/S
|
Computer software relating to the medical field; Computer software for use in medical decision su... |
|
|
Invention
|
Co-crystals of non-steroidal anti-inflammatory drugs, lysine and gabapentin, pharmaceutical compo... |
|
|
Invention
|
Raloxifene for use in the treatment of sars-cov-2 variants infections.
The present invention rel... |
|
|
Invention
|
Raloxifene for use in the treatment of sars-cov-2 variants infections. The present invention rela... |
|
|
Invention
|
Compounds for the treatment of covid-19. The present invention relates to compounds for the treat... |
|
|
G/S
|
Pharmaceutical products for the treatment of eye diseases;
pharmaceutical preparations for eyes ... |
|
|
Invention
|
New therapeutic use of type 2 iodothyronine deiodinase (d2) inhibitors.
Inhibitor compounds of t... |
|
|
Invention
|
New therapeutic use of type 2 iodothyronine deiodinase (d2) inhibitors. Inhibitor compounds of ty... |
|
|
Invention
|
Novel protein and nucleic acid sequences for covid-19 vaccines. The present invention relates to ... |
|
|
Invention
|
Deformable container, kit and packaging.
A deformable container for dispensing a medical substan... |
|
|
Invention
|
Treatment of neuropathic corneal pain with ngf.
The present invention relates to methods of trea... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of eye diseases, of pain, of febrile states and inf... |
|
|
G/S
|
Pharmaceutical preparations; disinfectants for hygiene. Downloadable computer software for use in... |
|
|
G/S
|
Pharmaceutical preparations excluding the foregoing for use
with blood-related cell processing d... |
|
|
G/S
|
Pharmaceutical preparation for the treatment of respiratory diseases; pharmaceutical preparation ... |
|
|
Invention
|
Combination therapy for covid-19 vaccination.
The present invention relates to the combination o... |
|
|
Invention
|
C5ar1 inhibitors for treating hypersensitivity reactions to taxanes.
The present invention relat... |
|
|
Invention
|
Cxcl8 inhibitor and pharmaceutical composition thereof for use in the treatment of seizures.
The... |
|
2021
|
Invention
|
Bdnf otic formulations and use thereof.
Disclosed herein are otic formulations and compositions ... |
|
|
G/S
|
Cough relief pharmaceuticals. |
|
|
Invention
|
Pharmaceutical packages comprising polypropylene containers and ngf aqueous formulations packaged... |
|
|
Invention
|
Peptides endowed with angiogenic activity.
The present invention relates to a peptide, or deriva... |
|
|
G/S
|
Pharmaceutical preparations, namely, for treatment of Covid19, acute respiratory distress syndrom... |
|
|
G/S
|
Pharmaceuticals, medical and veterinary preparations; Sanitary preparations for medical purposes;... |
|
|
Invention
|
New drug delivery system for ophtalmic use.
Object of the present invention is a drug delivery s... |
|
|
Invention
|
Compounds for the treatment of covid-19.
The present invention relates to compounds that are abl... |
|
|
Invention
|
Co-crystal of ketoprofen, lysine and gabapentin, pharmaceutical compositions and their medical us... |
|
|
Invention
|
Co-crystal of gabapentin, ketoprofen and lysine, pharmaceutical compositions and their medical us... |
|
|
Invention
|
Synergistic admixtures of gabapentin and ketoprofen, pharmaceutical compositions and their medica... |
|
|
G/S
|
Pharmaceuticals; medical tonics; dietetic supplements;
nutritional supplements; dietetic substan... |
|
|
Invention
|
Cxcl8 inhibitors for use in the treatment of covid-19.
The present invention relates to CXCL8 in... |
|
|
Invention
|
Cxcl8 inhibitor and pharmaceutical composition thereof for use in the treatment of cancer-related... |
|
|
Invention
|
Cxcl8 (interleukin-8) activity inhibitor and corticosteroid combination and pharmaceutical compos... |
|
|
G/S
|
Pharmaceutical products for the treatment of cough. |
|
|
Invention
|
Growth factor formulation for condition associated with otic event.
Disclosed herein are otic fo... |
|
2020
|
Invention
|
Co-crystal of ketoprofen and its preparation, pharmaceutical compositions comprising the same and... |
|
|
G/S
|
Nutritional supplements, dietetic foods and beverages adapted for medical use |
|
|
G/S
|
Pharmaceutical and veterinary preparations; sanitary
preparations for medical purposes; dietetic... |
|
|
G/S
|
Scientific, optical, weighing, measuring, signaling,
checking (inspection), life-saving and teac... |
|
|
G/S
|
Pharmaceuticals; Medical tonics; Nutritional supplements; Nutritional supplements; Dietetic subst... |
|
|
G/S
|
Scientific, optical, weighing, measuring, signalling, checking (supervision), life-saving and tea... |
|
|
G/S
|
downloadable computer software for use in identifying new drugs, namely, software that is able to... |
|
2019
|
G/S
|
Medical devices for measuring corneal sensitivity; Surgical and/or medical apparatus and instrume... |
|
|
Invention
|
Growth factor otic formulations.
Disclosed herein are otic formulations and compositions compris... |
|
2018
|
G/S
|
Pharmaceuticals and Medicinal specialities; Medicated antiemetic preparations; Medicated anti-nau... |
|
|
G/S
|
Perfume; Perfumery; Cosmetics; Skin and body beauty and care preparations, not for medical purpos... |
|
2017
|
G/S
|
Custom manufacture of pharmaceuticals. Development of pharmaceutical preparations and medicines; ... |
|
|
G/S
|
Pharmaceutical products for the treatment of eye diseases; pharmaceutical preparations for eyes f... |
|
|
G/S
|
Sterile solution for inhalation and intranasal administration; Inhalants; Dental preparations and... |
|
|
G/S
|
Pharmaceutical, veterinary and sanitary preparations; Dietetic substances adapted for medical use... |
|
2016
|
G/S
|
Pharmaceutical and veterinary products, substances and/or preparations; Sanitary preparations for... |
|
|
G/S
|
Pharmaceuticals for treating eye diseases; Pharmaceuticals for the eyes for medical purposes; Pha... |
|
2015
|
G/S
|
Pharmaceutical preparations; medicines; pharmaceutical
preparations; preparations for medical pu... |
|
|
G/S
|
Pharmaceutical products and preparations for treating obstructive disorders of the respiratory tr... |
